Sex hormone plasma levels in premenopausal women with coronary heart disease

Folia Cardiologica

Volumn 13, Issue 5, 2006, Pages 423-426

  Okraska Bylica, Agnieszka ^a   Paradowski, Andrzej ^a   Matysek, Jerzy ^a   Czubek, Urszula ^a   Piwowarska, Wiesława ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Coronary heart disease; Estradiol; Women

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; SEX HORMONE;

ADULT; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPOPITUITARISM; ISCHEMIC HEART DISEASE; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUATION; PREMENOPAUSE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 33747584932     PISSN: 15074145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Broda G. Epidemiologia chorób układu krażenia u kobiet. Kardiol Pol, 2000; 52 (Suppl III): III-6-III-9.
2. Światecka G, Kubica J, Reczuch K. Choroba niedokrwienna serca. In: Światecka G ed. Choroby serca u kobiet. Via Medica, Gdańsk 2000.
3. Skafar DF, Xu R, Morales J, Ram J, Sowers JR. Female sex hormones and cardiovascular disease in women. J Clin Endocrinol Metab, 1997; 82: 3913-3918.
4. Collins P, Rosano GM, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA. Hypothesis: cardiovascular protection by estrogen - a calcium antagonist effect? Lancet, 1993; 341: 1264-1265.
5. Liao D, Barnes RW, Chambless LE, Simpson RJ, Sorlie P, Heiss G. Age, race, and sex differences in autonomic cardiac function measured by spectral analysis of heart rate variability. The ARIC Study. Am J Cardiol, 1995; 76: 906-912.
6. Babiker FA, De Windt LJ, van Eickels M, Grohe C, Meyer R, Doevendans PA. Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc Res, 2002; 53: 709-719.
7. Roeters van Lennep JE, Westerveld HT, Erkelens DW, van der Wall EE. Risk factors for coronary heart disease: implications of gender. Cardiovasc Res, 2002; 53: 538-549.
8. Rossouw JE. Hormones, genetic factors, and gender differences in cardiovascular disease. Cardiovasc Res, 2002; 53: 550-557.
9. Spiridopoulos I, Sullivan AB, Kearney M, Isner JM, Losordo DW. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation, 1997; 95: 1505-1514.
10. Dart A, Du XJ, Kingwell BA. Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc Res, 2002; 53: 678-687
11. Kłoś J, Ceremuzyński L, Herbaczyńska-Cedro K. Obniżony poziom hormonów płciowych u kobiet z choroba niedokrwienna serca przed menopauza. Wpływ palenia papierosów. Kardiol Pol, 2001; 55: 305-307.
12. Merz CNB, Johnson BD, Sharaf BL et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: A report from the NHLBI - Sponsored WISE Study. J Am Coll Cardiol, 2003; 41: 413-419.
13. Malczewska B, Ostrzycki A, Szwed H et al. Influence of smoking on hormonal and lipid profile in premenopausal females. Kardiol Pol, 1999; 50: 101-106.
14. Słowińska-Strzednicka J, Malczewska B, Strzednicki M et al. Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease. J Intern Med, 1995; 237: 465-472.
15. Hashimoto M, Akishita M, Eto M et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation, 1995; 92: 3431-3435.
16. Collins P, Rosano GM, Sarrel PM et al. 17 beta-Estradiol attenuates acetylocholine-induced coronary arterial constriction in women but not men with coronary artery disease. Circulation, 1995; 92: 24-30.
17. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of estrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet, 1993; 342: 133-136.
18. Adams MR, Anthony MS, Manning JM et al. Low-dose contraceptive estrogen-progestin and coronary artery atherosclerosis of monkeys. Obstet Gynecol, 2000; 96: 250-255.
19. Angerer P, Stork S, Kothny W et al. Effect of oral postmenopausal estrogen replacement on progression of atherosclerosis. A randomized, controlled trial. Arterioscler Thromb Vasc Biol, 2001; 21: 262-268.
20. Herrington DM, Reboussin DM, Brosnihan KB et al. Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N Engl J Med, 2000; 343: 522-529.
21. Waters DD, Alderman EL, Hsia J et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA. 2002; 288: 2432-2440.
22. Hodis HN, Mack WJ, Lobo RA et al. Estrogen in the prevention of atherosclerosis trial. Circulation, 2000; 102 (Suppl II): 837 (abstract).